The role of BCR isotype in B-cell development and activation

Advances in Immunology

Volumn 123, Issue , 2014, Pages 101-139

  Surova, Elena ^a,b   Jumaa, Hassan ^a,b,c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

Autoreactivity; B cell development; Heavy chain isotype; Immunoglobulin

Indexed keywords

AUTOANTIGEN; B LYMPHOCYTE RECEPTOR; GALECTIN 1; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ALLELE; AMINO TERMINAL SEQUENCE; ANTIBODY PRODUCTION; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CELL MATURATION; COMPLEMENTARITY DETERMINING REGION; CONFORMATIONAL TRANSITION; GENE SWITCHING; HEAVY CHAIN; HUMAN; IMMUNOREACTIVITY; IMMUNOSTIMULATION; LIGHT CHAIN; MOLECULAR RECOGNITION; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY; STRUCTURE ACTIVITY RELATION; VDJ EXON;

AUTOREACTIVITY; B-CELL DEVELOPMENT; HEAVY-CHAIN ISOTYPE; IMMUNOGLOBULIN;

ANIMALS; B-LYMPHOCYTE SUBSETS; CELL DIFFERENTIATION; HUMANS; IMMUNOGLOBULIN DELTA-CHAINS; IMMUNOGLOBULIN GAMMA-CHAINS; IMMUNOGLOBULIN ISOTYPES; IMMUNOGLOBULIN MU-CHAINS; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, B-CELL;

EID: 84900829747     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800266-7.00003-0     Document Type: Chapter

References (187)

1. Achatz G., Nitschke L., Lamers M.C. Effect of transmembrane and cytoplasmic domains of IgE on the IgE response. Science 1997, 276(5311):409-411.
2. Ait-Azzouzene D., Verkoczy L., Peters J., Gavin A., Skog P., Vela J.L., et al. An immunoglobulin C kappa-reactive single chain antibody fusion protein induces tolerance through receptor editing in a normal polyclonal immune system. The Journal of Experimental Medicine 2005, 201(5):817-828.
3. Arnold L.W., Pennell C.A., McCray S.K., Clarke S.H. Development of B-1 cells: Segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression. The Journal of Experimental Medicine 1994, 179(5):1585-1595.
4. Arnold J.N., Wormald M.R., Sim R.B., Rudd P.M., Dwek R.A. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annual Review of Immunology 2007, 25:21-50.
5. Bankovich A.J., Raunser S., Juo Z.S., Walz T., Davis M.M., Garcia K.C. Structural insight into pre-B cell receptor function. Science 2007, 316(5822):291-294.
6. Billingham R.E., Brent L., Medawar P.B. The antigenic stimulus in transplantation immunity. Nature 1956, 178(4532):514-519.
7. Bradl H., Wittmann J., Milius D., Vettermann C., Jack H.M. Interaction of murine precursor B cell receptor with stroma cells is controlled by the unique tail of lambda 5 and stroma cell-associated heparan sulfate. The Journal of Immunology 2003, 171(5):2338-2348.
8. Brink R., Goodnow C.C., Basten A. IgD expression on B cells is more efficient than IgM but both receptors are functionally equivalent in up-regulation CD80/CD86 co-stimulatory molecules. European Journal of Immunology 1995, 25(7):1980-1984.
9. Brink R., Goodnow C.C., Crosbie J., Adams E., Eris J., Mason D.Y., et al. Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. The Journal of Experimental Medicine 1992, 176(4):991-1005.
10. Burnet F.M. Clonal selection theory of acquired immunity 1959, Cambridge University Press, London.
11. Cambier J.C., Gauld S.B., Merrell K.T., Vilen B.J. B-cell anergy: From transgenic models to naturally occurring anergic B cells?. Nature Reviews. Immunology 2007, 7(8):633-643.
12. Carsetti R., Kohler G., Lamers M.C. A role for immunoglobulin D: Interference with tolerance induction. European Journal of Immunology 1993, 23(1):168-178.
13. Casellas R., Shih T.A., Kleinewietfeld M., Rakonjac J., Nemazee D., Rajewsky K., et al. Contribution of receptor editing to the antibody repertoire. Science 2001, 291(5508):1541-1544.
14. Casola S., Otipoby K.L., Alimzhanov M., Humme S., Uyttersprot N., Kutok J.L., et al. B cell receptor signal strength determines B cell fate. Nature Immunology 2004, 5(3):317-327.
15. Cerny A., Heusser C., Sutter S., Huegin A.W., Bazin H., Hengartner H., et al. Generation of agammaglobulinaemic mice by prenatal and postnatal exposure to polyclonal or monoclonal anti-IgM antibodies. Scandinavian Journal of Immunology 1986, 24(4):437-445.
16. Chen C., Nagy Z., Prak E.L., Weigert M. Immunoglobulin heavy chain gene replacement: A mechanism of receptor editing. Immunity 1995, 3(6):747-755.
17. Cheng A.M., Rowley B., Pao W., Hayday A., Bolen J.B., Pawson T. Syk tyrosine kinase required for mouse viability and B-cell development. Nature 1995, 378(6554):303-306.
18. Choi N.M., Loguercio S., Verma-Gaur J., Degner S.C., Torkamani A., Su A.I., et al. Deep sequencing of the murine IgH repertoire reveals complex regulation of nonrandom v gene rearrangement frequencies. The Journal of Immunology 2013, 191(5):2393-2402.
19. Cooper L.J., Robertson D., Granzow R., Greenspan N.S. Variable domain-identical antibodies exhibit IgG subclass-related differences in affinity and kinetic constants as determined by surface plasmon resonance. Molecular Immunology 1994, 31(8):577-584.
20. Corper A.L., Sohi M.K., Bonagura V.R., Steinitz M., Jefferis R., Feinstein A., et al. Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction. Nature Structural Biology 1997, 4(5):374-381.
21. Dalziel M., Crispin M., Scanlan C.N., Zitzmann N., Dwek R.A. Emerging principles for the therapeutic exploitation of glycosylation. Science 2014, 343(6166):37-45.
22. Davis R.E., Ngo V.N., Lenz G., Tolar P., Young R.M., Romesser P.B., et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 2010, 463(7277):88-92.
23. De Genst E., Saerens D., Muyldermans S., Conrath K. Antibody repertoire development in camelids. Developmental and Comparative Immunology 2006, 30(1-2):187-198.
24. Dougan S.K., Ogata S., Hu C.C., Grotenbreg G.M., Guillen E., Jaenisch R., et al. IgG1+ ovalbumin-specific B-cell transnuclear mice show class switch recombination in rare allelically included B cells. Proceedings of the National Academy of Sciences of the United States of America 2012, 109(34):13739-13744. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't].
25. Doyle-Cooper C., Hudson K.E., Cooper A.B., Ota T., Skog P., Dawson P.E., et al. Immune tolerance negatively regulates B cells in knock-in mice expressing broadly neutralizing HIV antibody 4E10. The Journal of Immunology 2013, 191(6):3186-3191.
26. Duhren-von Minden M., Ubelhart R., Schneider D., Wossning T., Bach M.P., Buchner M., et al. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature 2012, 489(7415):309-312.
27. Edholm E.S., Bengten E., Wilson M. Insights into the function of IgD. Developmental and Comparative Immunology 2011, 35(12):1309-1316.
28. Egle A., Harris A.W., Bath M.L., O'Reilly L., Cory S. VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. Blood 2004, 103(6):2276-2283.
29. Elantak L., Espeli M., Boned A., Bornet O., Bonzi J., Gauthier L., et al. Structural basis for galectin-1-dependent pre-B cell receptor (pre-BCR) activation. The Journal of Biological Chemistry 2012, 287(53):44703-44713.
30. Engels N., Konig L.M., Heemann C., Lutz J., Tsubata T., Griep S., et al. Recruitment of the cytoplasmic adaptor Grb2 to surface IgG and IgE provides antigen receptor-intrinsic costimulation to class-switched B cells. Nature Immunology 2009, 10(9):1018-1025. 10.1038/ni.1764.
31. Erikson J., Radic M.Z., Camper S.A., Hardy R.R., Carmack C., Weigert M. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 1991, 349(6307):331-334.
32. Eschbach C., Bach M.P., Fidler I., Pelanda R., Kohler F., Rajewsky K., et al. Efficient generation of B lymphocytes by recognition of self-antigens. European Journal of Immunology 2011, 41(8):2397-2403.
33. Espeli M., Mancini S.J., Breton C., Poirier F., Schiff C. Impaired B-cell development at the pre-BII-cell stage in galectin-1-deficient mice due to inefficient pre-BII/stromal cell interactions. Blood 2009, 113(23):5878-5886.
34. Finkelman F.D., Mond J.J., Metcalf E.S. Effects of neonatal anti-delta antibody treatment on the murine immune system. I. Suppression of development of surface IgD+ B cells and expansion of a surface IgM+ IgD- B lymphocyte population. The Journal of Immunology 1983, 131(2):593-600.
35. Flajnik M.F. Comparative analyses of immunoglobulin genes: Surprises and portents. Nature Reviews. Immunology 2002, 2(9):688-698.
36. Galler G.R., Mundt C., Parker M., Pelanda R., Martensson I.L., Winkler T.H. Surface mu heavy chain signals down-regulation of the V(D)J-recombinase machinery in the absence of surrogate light chain components. The Journal of Experimental Medicine 2004, 199(11):1523-1532.
37. Gauthier L., Rossi B., Roux F., Termine E., Schiff C. Galectin-1 is a stromal cell ligand of the pre-B cell receptor (BCR) implicated in synapse formation between pre-B and stromal cells and in pre-BCR triggering. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(20):13014-13019.
38. Gay D., Saunders T., Camper S., Weigert M. Receptor editing: An approach by autoreactive B cells to escape tolerance. The Journal of Experimental Medicine 1993, 177(4):999-1008.
39. Goodnow C.C., Crosbie J., Adelstein S., Lavoie T.B., Smith-Gill S.J., Brink R.A., et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988, 334(6184):676-682.
40. Gordon J., Murgita R.A., Tomasi T.B. The immune response of mice treated with anti-mu antibodies: The effect on antibody-forming cells, their precursors and helper cells assayed in vitro. The Journal of Immunology 1975, 114(6):1808-1812.
41. Grandien A., Fucs R., Nobrega A., Andersson J., Coutinho A. Negative selection of multireactive B cell clones in normal adult mice. European Journal of Immunology 1994, 24(6):1345-1352.
42. Grawunder U., Leu T.M., Schatz D.G., Werner A., Rolink A.G., Melchers F., et al. Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement. Immunity 1995, 3(5):601-608.
43. Greenspan N.S., Cooper L.J. Cooperative binding by mouse IgG3 antibodies: Implications for functional affinity, effector function, and isotype restriction. Springer Seminars in Immunopathology 1993, 15(2-3):275-291.
44. Harwood N.E., Batista F.D. Early Events in B Cell Activation. Annual Review of Immunology 2010, 28(1):185-210.
45. Hasan M., Polic B., Bralic M., Jonjic S., Rajewsky K. Incomplete block of B cell development and immunoglobulin production in mice carrying the μ MT mutation on the BALB/c background. European Journal of Immunology 2002, 32(12):3463-3471.
46. Hauser J., Sveshnikova N., Wallenius A., Baradaran S., Saarikettu J., Grundstrom T. B-cell receptor activation inhibits AID expression through calmodulin inhibition of E-proteins. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(4):1267-1272.
47. Hayakawa K., Asano M., Shinton S.A., Gui M., Allman D., Stewart C.L., et al. Positive selection of natural autoreactive B cells. Science 1999, 285(5424):113-116.
48. Herzog S., Hug E., Meixlsperger S., Paik J.H., DePinho R.A., Reth M., et al. SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway. Nature Immunology 2008, 9(6):623-631.
49. Herzog S., Reth M., Jumaa H. Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nature Reviews. Immunology 2009, 9(3):195-205.
50. Hess J., Werner A., Wirth T., Melchers F., Jack H.M., Winkler T.H. Induction of pre-B cell proliferation after de novo synthesis of the pre-B cell receptor. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(4):1745-1750.
51. Hippen K.L., Schram B.R., Tze L.E., Pape K.A., Jenkins M.K., Behrens T.W. In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance. The Journal of Immunology 2005, 175(2):909-916.
52. Horikawa K., Martin S.W., Pogue S.L., Silver K., Peng K., Takatsu K., et al. Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors. The Journal of Experimental Medicine 2007, 204(4):759-769.
53. Hug E., Hobeika E., Reth M., Jumaa H. Inducible expression of hyperactive Syk in B cells activates Blimp-1-dependent terminal differentiation. Oncogene 2013, 10.1038/onc.2013.326.
54. James L.C., Roversi P., Tawfik D.S. Antibody multispecificity mediated by conformational diversity. Science 2003, 299(5611):1362-1367.
55. Janssens R., Dekker S., Hendriks R.W., Panayotou G., van Remoortere A., San J.K., et al. Generation of heavy-chain-only antibodies in mice. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(41):15130-15135.
56. Jiang H., Chang F.C., Ross A.E., Lee J., Nakayama K., Desiderio S. Ubiquitylation of RAG-2 by Skp2-SCF links destruction of the V(D)J recombinase to the cell cycle. Molecular Cell 2005, 18(6):699-709.
57. Johnston C.M., Wood A.L., Bolland D.J., Corcoran A.E. Complete sequence assembly and characterization of the C57BL/6 mouse Ig heavy chain V region. The Journal of Immunology 2006, 176(7):4221-4234.
58. Jumaa H., Wollscheid B., Mitterer M., Wienands J., Reth M., Nielsen P.J. Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65. Immunity 1999, 11(5):547-554.
59. Kaisho T., Schwenk F., Rajewsky K. The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses. Science 1997, 276(5311):412-415.
60. Karasuyama H., Kudo A., Melchers F. The proteins encoded by the VpreB and lambda 5 pre-B cell-specific genes can associate with each other and with mu heavy chain. The Journal of Experimental Medicine 1990, 172(3):969-972.
61. Karasuyama H., Rolink A., Melchers F. A complex of glycoproteins is associated with VpreB/lambda 5 surrogate light chain on the surface of mu heavy chain-negative early precursor B cell lines. The Journal of Experimental Medicine 1993, 178(2):469-478.
62. Karasuyama H., Rolink A., Shinkai Y., Young F., Alt F.W., Melchers F. The expression of Vpre-B/lambda 5 surrogate light chain in early bone marrow precursor B cells of normal and B cell-deficient mutant mice. Cell 1994, 77(1):133-143.
63. Keenan R.A., De Riva A., Corleis B., Hepburn L., Licence S., Winkler T.H., et al. Censoring of autoreactive B cell development by the pre-B cell receptor. Science 2008, 321(5889):696-699.
64. Keyna U., Applequist S.E., Jongstra J., Beck-Engeser G.B., Jack H.M. Ig mu heavy chains with VH81X variable regions do not associate with lambda 5. Annals of the New York Academy of Sciences 1995, 764:39-42.
65. Keyna U., Beck-Engeser G.B., Jongstra J., Applequist S.E., Jack H.M. Surrogate light chain-dependent selection of Ig heavy chain V regions. The Journal of Immunology 1995, 155(12):5536-5542.
66. Kim K.M., Reth M. The B cell antigen receptor of class IgD induces a stronger and more prolonged protein tyrosine phosphorylation than that of class IgM. The Journal of Experimental Medicine 1995, 181(3):1005-1014.
67. Kitamura D., Kudo A., Schaal S., Muller W., Melchers F., Rajewsky K. A critical role of lambda 5 protein in B cell development. Cell 1992, 69(5):823-831.
68. Kitamura D., Rajewsky K. Targeted disruption of mu chain membrane exon causes loss of heavy-chain allelic exclusion. Nature 1992, 356(6365):154-156.
69. Koelsch K., Zheng N.Y., Zhang Q., Duty A., Helms C., Mathias M.D., et al. Mature B cells class switched to IgD are autoreactive in healthy individuals. The Journal of Clinical Investigation 2007, 117(6):1558-1565.
70. Kohler F., Hug E., Eschbach C., Meixlsperger S., Hobeika E., Kofer J., et al. Autoreactive B cell receptors mimic autonomous pre-B cell receptor signaling and induce proliferation of early B cells. Immunity 2008, 29(6):912-921.
71. Kometani K., Nakagawa R., Shinnakasu R., Kaji T., Rybouchkin A., Moriyama S., et al. Repression of the transcription factor Bach2 contributes to predisposition of IgG1 memory B cells toward plasma cell differentiation. Immunity 2013, 39(1):136-147.
72. Kraus M., Alimzhanov M.B., Rajewsky N., Rajewsky K. Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell 2004, 117(6):787-800.
73. Kreslavsky T., Kim H.-J., Koralov S.B., Ghitza D., Buch T., Cantor H., et al. Negative selection, not receptor editing, is a physiological response of autoreactive thymocytes. The Journal of Experimental Medicine 2013, 210(10):1911-1918.
74. Kurosaki T. Regulation of BCR signaling. Molecular Immunology 2011, 48(11):1287-1291.
75. Lam K.P., Kuhn R., Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 1997, 90(6):1073-1083.
76. Lang J., Jackson M., Teyton L., Brunmark A., Kane K., Nemazee D. B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen. The Journal of Experimental Medicine 1996, 184(5):1685-1697.
77. Lawton A.R., Asofsky R., Hylton M.B., Cooper M.D. Suppression of immunoglobulin class synthesis in mice. I. Effects of treatment with antibody to -chain. The Journal of Experimental Medicine 1972, 135(2):277-297.
78. Lenz G., Nagel I., Siebert R., Roschke A.V., Sanger W., Wright G.W., et al. Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma. The Journal of Experimental Medicine 2007, 204(3):633-643.
79. Li Z., Dordai D.I., Lee J., Desiderio S. A conserved degradation signal regulates RAG-2 accumulation during cell division and links V(D)J recombination to the cell cycle. Immunity 1996, 5(6):575-589.
80. Lin W.C., Desiderio S. Cell cycle regulation of V(D)J recombination-activating protein RAG-2. Proceedings of the National Academy of Sciences of the United States of America 1994, 91(7):2733-2737.
81. Liu F., Bergami P.L., Duval M., Kuhrt D., Posner M., Cavacini L. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120. AIDS Research and Human Retroviruses 2003, 19(7):597-607.
82. Liu H., May K. Disulfide bond structures of IgG molecules: Structural variations, chemical modifications and possible impacts to stability and biological function. MAbs 2012, 4(1):17-23.
83. Lutz C., Ledermann B., Kosco-Vilbois M.H., Ochsenbein A.F., Zinkernagel R.M., Kohler G., et al. IgD can largely substitute for loss of IgM function in B cells. Nature 1998, 393(6687):797-801.
84. Macpherson A.J., Lamarre A., McCoy K., Harriman G.R., Odermatt B., Dougan G., et al. IgA production without mu or delta chain expression in developing B cells. Nature Immunology 2001, 2(7):625-631.
85. Magadan-Mompo S., Sanchez-Espinel C., Gambon-Deza F. Immunoglobulin heavy chains in medaka (Oryzias latipes). BMC Evolutionary Biology 2011, 11:165.
86. Manivel V., Sahoo N.C., Salunke D.M., Rao K.V. Maturation of an antibody response is governed by modulations in flexibility of the antigen-combining site. Immunity 2000, 13(5):611-620.
87. Manning D.D., Jutila J.W. Immunosuppression of mice injected with heterologous anti-immunoglobulin heavy chain antisera. The Journal of Experimental Medicine 1972, 135(6):1316-1333.
88. Martensson A., Argon Y., Melchers F., Dul J.L., Martensson I.L. Partial block in B lymphocyte development at the transition into the pre-B cell receptor stage in Vpre-B1-deficient mice. International Immunology 1999, 11(3):453-460.
89. Martin D.A., Bradl H., Collins T.J., Roth E., Jack H.M., Wu G.E. Selection of Ig mu heavy chains by complementarity-determining region 3 length and amino acid composition. The Journal of Immunology 2003, 171(9):4663-4671.
90. Martin S.W., Goodnow C.C. Burst-enhancing role of the IgG membrane tail as a molecular determinant of memory. Nature Immunology 2002, 3(2):182-188.
91. Mattila P.K., Feest C., Depoil D., Treanor B., Montaner B., Otipoby K.L., et al. The actin and tetraspanin networks organize receptor nanoclusters to regulate B cell receptor-mediated signaling. Immunity 2013, 38(3):461-474.
92. McDonnell T.J., Deane N., Platt F.M., Nunez G., Jaeger U., McKearn J.P., et al. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989, 57(1):79-88.
93. Meixlsperger S., Kohler F., Wossning T., Reppel M., Muschen M., Jumaa H. Conventional light chains inhibit the autonomous signaling capacity of the B cell receptor. Immunity 2007, 26(3):323-333.
94. Melamed D., Miri E., Leider N., Nemazee D. Unexpected autoantibody production in membrane Ig-mu-deficient/lpr mice. The Journal of Immunology 2000, 165(8):4353-4358.
95. Melchers F. The pre-B-cell receptor: Selector of fitting immunoglobulin heavy chains for the B-cell repertoire. Nature Reviews. Immunology 2005, 5(7):578-584.
96. Meng W., Yunk L., Wang L.S., Maganty A., Xue E., Cohen P.L., et al. Selection of individual VH genes occurs at the pro-B to pre-B cell transition. The Journal of Immunology 2011, 187(4):1835-1844.
97. Menoret S., Iscache A.L., Tesson L., Remy S., Usal C., Osborn M.J., et al. Characterization of immunoglobulin heavy chain knockout rats. European Journal of Immunology 2010, 40(10):2932-2941.
98. Minegishi Y., Conley M.E. Negative selection at the pre-BCR checkpoint elicited by human mu heavy chains with unusual CDR3 regions. Immunity 2001, 14(5):631-641.
99. Minegishi Y., Coustan-Smith E., Wang Y.H., Cooper M.D., Campana D., Conley M.E. Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia. The Journal of Experimental Medicine 1998, 187(1):71-77.
100. Minegishi Y., Hendershot L.M., Conley M.E. Novel mechanisms control the folding and assembly of lambda5/14.1 and VpreB to produce an intact surrogate light chain. Proceedings of the National Academy of Sciences of the United States of America 1999, 96(6):3041-3046.
101. Misener V., Downey G.P., Jongstra J. The immunoglobulin light chain related protein lambda 5 is expressed on the surface of mouse pre-B cell lines and can function as a signal transducing molecule. International Immunology 1991, 3(11):1129-1136.
102. Montesinos-Rongen M., Schmitz R., Courts C., Stenzel W., Bechtel D., Niedobitek G., et al. Absence of immunoglobulin class switch in primary lymphomas of the central nervous system. The American Journal of Pathology 2005, 166(6):1773-1779.
103. Morahan G., Berek C., Miller J.F. An idiotypic determinant formed by both immunoglobulin constant and variable regions. Nature 1983, 301(5902):720-722.
104. Morelock M.M., Rothlein R., Bright S.M., Robinson M.K., Graham E.T., Sabo J.P., et al. Isotype choice for chimeric antibodies affects binding properties. The Journal of Biological Chemistry 1994, 269(17):13048-13055.
105. Mundt C., Licence S., Shimizu T., Melchers F., Martensson I.L. Loss of precursor B cell expansion but not allelic exclusion in VpreB1/VpreB2 double-deficient mice. The Journal of Experimental Medicine 2001, 193(4):435-445.
106. Nagata K., Nakamura T., Kitamura F., Kuramochi S., Taki S., Campbell K.S., et al. The Ig alpha/Igbeta heterodimer on mu-negative proB cells is competent for transducing signals to induce early B cell differentiation. Immunity 1997, 7(4):559-570.
107. Nardini E., Rizzi S., Capello D., Vitolo U., Gaidano G., Menard S., et al. Most immunoglobulin heavy chain switch mu rearrangements in B-cell chronic lymphocytic leukemia are internal deletions. FEBS Letters 2002, 518(1-3):119-123.
108. Nemazee D., Buerki K. Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras. Proceedings of the National Academy of Sciences of the United States of America 1989, 86(20):8039-8043.
109. Nemazee D.A., Burki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 1989, 337(6207):562-566.
110. Nemazee D., Weigert M. Revising B cell receptors. The Journal of Experimental Medicine 2000, 191(11):1813-1817.
111. Nitschke L., Kosco M.H., Kohler G., Lamers M.C. Immunoglobulin D-deficient mice can mount normal immune responses to thymus-independent and -dependent antigens. Proceedings of the National Academy of Sciences of the United States of America 1993, 90(5):1887-1891.
112. Novobrantseva T.I., Martin V.M., Pelanda R., Muller W., Rajewsky K., Ehlich A. Rearrangement and expression of immunoglobulin light chain genes can precede heavy chain expression during normal B cell development in mice. The Journal of Experimental Medicine 1999, 189(1):75-88.
113. Novobrantseva T., Xu S., Tan J.E.-L., Maruyama M., Schwers S., Pelanda R., et al. Stochastic pairing of Ig heavy and light chains frequently generates B cell antigen receptors that are subject to editing in vivo. International Immunology 2005, 17(4):343-350.
114. Ohnishi K., Melchers F. The nonimmunoglobulin portion of lambda5 mediates cell-autonomous pre-B cell receptor signaling. Nature Immunology 2003, 4(9):849-856.
115. Ohnishi K., Melchers F., Shimizu T. Lymphocyte-expressed BILL-cadherin/cadherin-17 contributes to the development of B cells at two stages. European Journal of Immunology 2005, 35(3):957-963.
116. Ohnishi K., Shimizu T., Karasuyama H., Melchers F. The identification of a nonclassical cadherin expressed during B cell development and its interaction with surrogate light chain. The Journal of Biological Chemistry 2000, 275(40):31134-31144.
117. Ohta Y., Flajnik M. IgD, like IgM, is a primordial immunoglobulin class perpetuated in most jawed vertebrates. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(28):10723-10728.
118. Okkenhaug K., Bilancio A., Farjot G., Priddle H., Sancho S., Peskett E., et al. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science 2002, 297(5583):1031-1034.
119. Ozato K., Mayer N., Sachs D.H. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. The Journal of Immunology 1980, 124(2):533-540.
120. Papavasiliou F., Misulovin Z., Suh H., Nussenzweig M.C. The role of Ig beta in precursor B cell transition and allelic exclusion. Science 1995, 268(5209):408-411.
121. Parker M.J., Licence S., Erlandsson L., Galler G.R., Chakalova L., Osborne C.S., et al. The pre-B-cell receptor induces silencing of VpreB and lambda5 transcription. The EMBO Journal 2005, 24(22):3895-3905.
122. Pelanda R., Braun U., Hobeika E., Nussenzweig M.C., Reth M. B cell progenitors are arrested in maturation but have intact VDJ recombination in the absence of Ig-alpha and Ig-beta. The Journal of Immunology 2002, 169(2):865-872.
123. Pelanda R., Schaal S., Torres R.M., Rajewsky K. A prematurely expressed Ig(kappa) transgene, but not V(kappa)J(kappa) gene segment targeted into the Ig(kappa) locus, can rescue B cell development in lambda5-deficient mice. Immunity 1996, 5(3):229-239.
124. Pelanda R., Schwers S., Sonoda E., Torres R.M., Nemazee D., Rajewsky K. Receptor editing in a transgenic mouse model: Site, efficiency, and role in B cell tolerance and antibody diversification. Immunity 1997, 7(6):765-775.
125. Pelanda R., Torres R.M. Central B-cell tolerance: Where selection begins. Cold Spring Harbor Perspectives in Biology 2012, 4(4):a007146. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't].
126. Pennell C.A., Mercolino T.J., Grdina T.A., Arnold L.W., Haughton G., Clarke S.H. Biased immunoglobulin variable region gene expression by Ly-1 B cells due to clonal selection. European Journal of Immunology 1989, 19(7):1289-1295.
127. Perlmutter R.M., Kearney J.F., Chang S.P., Hood L.E. Developmentally controlled expression of immunoglobulin VH genes. Science 1985, 227(4694):1597-1601.
128. Pewzner-Jung Y., Friedmann D., Sonoda E., Jung S., Rajewsky K., Eilat D. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain. The Journal of Immunology 1998, 161(9):4634-4645.
129. Pogue S.L., Goodnow C.C. Ig heavy chain extracellular spacer confers unique glycosylation of the Mb-1 component of the B cell antigen receptor complex. The Journal of Immunology 1994, 152(8):3925-3934.
130. Pritsch O., Hudry-Clergeon G., Buckle M., Petillot Y., Bouvet J.P., Gagnon J., et al. Can immunoglobulin C(H)1 constant region domain modulate antigen binding affinity of antibodies?. The Journal of Clinical Investigation 1996, 98(10):2235-2243.
131. Pritsch O., Magnac C., Dumas G., Bouvet J.P., Alzari P., Dighiero G. Can isotype switch modulate antigen-binding affinity and influence clonal selection?. European Journal of Immunology 2000, 30(12):3387-3395.
132. Quach T.D., Manjarrez-Orduno N., Adlowitz D.G., Silver L., Yang H., Wei C., et al. Anergic responses characterize a large fraction of human autoreactive naive B cells expressing low levels of surface IgM. The Journal of Immunology 2011, 186(8):4640-4648.
133. Radic M.Z., Weigert M. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annual Review of Immunology 1994, 12:487-520.
134. Ramadani F., Bolland D.J., Garcon F., Emery J.L., Vanhaesebroeck B., Corcoran A.E., et al. The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development. Science Signaling 2010, 3(134):ra60.
135. Reth M. Antigen receptors on B lymphocytes. Annual Review of Immunology 1992, 10:97-121.
136. Rickert R.C. New insights into pre-BCR and BCR signalling with relevance to B cell malignancies. Nature Reviews. Immunology 2013, 13(8):578-591.
137. Robbins G.R., Knight K.L. Mechanism for pre-B cell loss in VH-mutant rabbits. The Journal of Immunology 2011, 187(9):4714-4720.
138. Roes J., Rajewsky K. Immunoglobulin D (IgD)-deficient mice reveal an auxiliary receptor function for IgD in antigen-mediated recruitment of B cells. The Journal of Experimental Medicine 1993, 177(1):45-55.
139. Rogers K.A., Richardson J.P., Scinicariello F., Attanasio R. Molecular characterization of immunoglobulin D in mammals: Immunoglobulin heavy constant delta genes in dogs, chimpanzees and four old world monkey species. Immunology 2006, 118(1):88-100.
140. Rolink A.G., Winkler T., Melchers F., Andersson J. Precursor B cell receptor-dependent B cell proliferation and differentiation does not require the bone marrow or fetal liver environment. The Journal of Experimental Medicine 2000, 191(1):23-32.
141. Ruminy P., Etancelin P., Couronne L., Parmentier F., Rainville V., Mareschal S., et al. The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma. Leukemia 2011, 25(4):681-688.
142. Saha N., Suetake H., Kikuchi K., Suzuki Y. Fugu immunoglobulin D: A highly unusual gene with unprecedented duplications in its constant region. Immunogenetics 2004, 56(6):438-447.
143. Schebesta M., Pfeffer P.L., Busslinger M. Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene. Immunity 2002, 17(4):473-485.
144. Schuh W., Meister S., Roth E., Jack H.M. Cutting edge: Signaling and cell surface expression of a mu H chain in the absence of lambda 5: A paradigm revisited. The Journal of Immunology 2003, 171(7):3343-3347.
145. Schweighoffer E., Vanes L., Nys J., Cantrell D., McCleary S., Smithers N., et al. The BAFF receptor transduces survival signals by co-opting the B cell receptor signaling pathway. Immunity 2013, 38(3):475-488.
146. Sela-Culang I., Alon S., Ofran Y. A systematic comparison of free and bound antibodies reveals binding-related conformational changes. The Journal of Immunology 2012, 189(10):4890-4899.
147. Shimizu T., Mundt C., Licence S., Melchers F., Martensson I.L. VpreB1/VpreB2/lambda 5 triple-deficient mice show impaired B cell development but functional allelic exclusion of the IgH locus. The Journal of Immunology 2002, 168(12):6286-6293.
148. Simons K., Toomre D. Lipid rafts and signal transduction. Nature Reviews. Molecular Cell Biology 2000, 1(1):31-39. 10.1038/35036052.
149. Srinivasan L., Sasaki Y., Calado D.P., Zhang B., Paik J.H., DePinho R.A., et al. PI3 kinase signals BCR-dependent mature B cell survival. Cell 2009, 139(3):573-586.
150. Stenvik J., Jorgensen T.O. Immunoglobulin D (IgD) of Atlantic cod has a unique structure. Immunogenetics 2000, 51(6):452-461.
151. Su Y.W., Flemming A., Wossning T., Hobeika E., Reth M., Jumaa H. Identification of a pre-BCR lacking surrogate light chain. The Journal of Experimental Medicine 2003, 198(11):1699-1706.
152. Subrahmanyam R., Sen R. Epigenetic features that regulate IgH locus recombination and expression. Current Topics in Microbiology and Immunology 2012, 356:39-63.
153. Suzuki H., Terauchi Y., Fujiwara M., Aizawa S., Yazaki Y., Kadowaki T., et al. Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science 1999, 283(5400):390-392.
154. Takemori T., Rajewsky K. Specificity, duration and mechanism of idiotype suppression induced by neonatal injection of monoclonal anti-idiotope antibodies into mice. European Journal of Immunology 1984, 14(7):656-667.
155. ten Boekel E., Melchers F., Rolink A.G. Changes in the V(H) gene repertoire of developing precursor B lymphocytes in mouse bone marrow mediated by the pre-B cell receptor. Immunity 1997, 7(3):357-368.
156. Tiegs S.L., Russell D.M., Nemazee D. Receptor editing in self-reactive bone marrow B cells. The Journal of Experimental Medicine 1993, 177(4):1009-1020.
157. Tokuhisa T., Gadus F.T., Herzenberg L.A. Monoclonal antibody to an IgD allotype induces a new type of allotype suppression in the mouse. The Journal of Experimental Medicine 1981, 154(3):921-934.
158. Tongren J.E., Corran P.H., Jarra W., Langhorne J., Riley E.M. Epitope-specific regulation of immunoglobulin class switching in mice immunized with malarial merozoite surface proteins. Infection and Immunity 2005, 73(12):8119-8129.
159. Tornberg U.C., Holmberg D. B-1a, B-1b and B-2 B cells display unique VHDJH repertoires formed at different stages of ontogeny and under different selection pressures. The EMBO Journal 1995, 14(8):1680-1689.
160. Torres M., Fernandez-Fuentes N., Fiser A., Casadevall A. The immunoglobulin heavy chain constant region affects kinetic and thermodynamic parameters of antibody variable region interactions with antigen. The Journal of Biological Chemistry 2007, 282(18):13917-13927.
161. Treanor B. B-cell receptor: From resting state to activate. Immunology 2012, 136(1):21-27.
162. Treanor B., Depoil D., Gonzalez-Granja A., Barral P., Weber M., Dushek O., et al. The membrane skeleton controls diffusion dynamics and signaling through the B cell receptor. Immunity 2010, 32(2):187-199.
163. Tsubata T., Reth M. The products of pre-B cell-specific genes (lambda 5 and VpreB) and the immunoglobulin mu chain form a complex that is transported onto the cell surface. The Journal of Experimental Medicine 1990, 172(3):973-976.
164. Tudor D., Yu H., Maupetit J., Drillet A.-S., Bouceba T., Schwartz-Cornil I., et al. Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody. Proceedings of the National Academy of Sciences 2012, 109(31):12680-12685.
165. Turner M., Mee P.J., Costello P.S., Williams O., Price A.A., Duddy L.P., et al. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 1995, 378(6554):298-302.
166. Tze L.E., Schram B.R., Lam K.P., Hogquist K.A., Hippen K.L., Liu J., et al. Basal immunoglobulin signaling actively maintains developmental stage in immature B cells. PLoS Biology 2005, 3(3):e82.
167. Ubelhart R., Bach M.P., Eschbach C., Wossning T., Reth M., Jumaa H. N-linked glycosylation selectively regulates autonomous precursor BCR function. Nature Immunology 2010, 11(8):759-765.
168. Vaandrager J.W., Schuuring E., Kluin-Nelemans H.C., Dyer M.J., Raap A.K., Kluin P.M. DNA fiber fluorescence in situ hybridization analysis of immunoglobulin class switching in B-cell neoplasia: Aberrant CH gene rearrangements in follicle center-cell lymphoma. Blood 1998, 92(8):2871-2878.
169. Vettermann C., Herrmann K., Albert C., Roth E., Bosl M.R., Jack H.M. A unique role for the lambda5 nonimmunoglobulin tail in early B lymphocyte development. The Journal of Immunology 2008, 181(5):3232-3242.
170. Vettermann C., Schlissel M.S. Allelic exclusion of immunoglobulin genes: Models and mechanisms. Immunological Reviews 2010, 237(1):22-42.
171. Waisman A., Kraus M., Seagal J., Ghosh S., Melamed D., Song J., et al. IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig alpha/beta. The Journal of Experimental Medicine 2007, 204(4):747-758. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't].
172. Wakabayashi C., Adachi T., Wienands J., Tsubata T. A distinct signaling pathway used by the IgG-containing B cell antigen receptor. Science 2002, 298(5602):2392-2395.
173. Wang F., Ekiert D.C., Ahmad I., Yu W., Zhang Y., Bazirgan O., et al. Reshaping antibody diversity. Cell 2013, 153(6):1379-1393.
174. Wardemann H., Yurasov S., Schaefer A., Young J.W., Meffre E., Nussenzweig M.C. Predominant autoantibody production by early human B cell precursors. Science 2003, 301(5638):1374-1377.
175. Wasserman R., Li Y.S., Hardy R.R. Down-regulation of terminal deoxynucleotidyl transferase by Ig heavy chain in B lineage cells. The Journal of Immunology 1997, 158(3):1133-1138.
176. Wedemayer G.J., Patten P.A., Wang L.H., Schultz P.G., Stevens R.C. Structural insights into the evolution of an antibody combining site. Science 1997, 276(5319):1665-1669.
177. Wen L., Brill-Dashoff J., Shinton S.A., Asano M., Hardy R.R., Hayakawa K. Evidence of marginal-zone B cell-positive selection in spleen. Immunity 2005, 23(3):297-308.
178. Werner M., Hobeika E., Jumaa H. Role of PI3K in the generation and survival of B cells. Immunological Reviews 2010, 237(1):55-71.
179. Wienands J., Reth M. Glycosyl-phosphatidylinositol linkage as a mechanism for cell-surface expression of immunoglobulin D. Nature 1992, 356(6366):246-248. 10.1038/356246a0.
180. Wilson M., Bengten E., Miller N.W., Clem L.W., Du Pasquier L., Warr G.W. A novel chimeric Ig heavy chain from a teleost fish shares similarities to IgD. Proceedings of the National Academy of Sciences of the United States of America 1997, 94(9):4593-4597.
181. Yancopoulos G.D., Desiderio S.V., Paskind M., Kearney J.F., Baltimore D., Alt F.W. Preferential utilization of the most JH-proximal VH gene segments in pre-B-cell lines. Nature 1984, 311(5988):727-733.
182. Yang J., Reth M. The dissociation activation model of B cell antigen receptor triggering. FEBS Letters 2010, 584(24):4872-4877.
183. Yel L., Minegishi Y., Coustan-Smith E., Buckley R.H., Trubel H., Pachman L.M., et al. Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. The New England Journal of Medicine 1996, 335(20):1486-1493.
184. Young R.M., Staudt L.M. Targeting pathological B cell receptor signalling in lymphoid malignancies. Nature Reviews. Drug Discovery 2013, 12(3):229-243.
185. Zhao Y., Kacskovics I., Pan Q., Liberles D.A., Geli J., Davis S.K., et al. Artiodactyl IgD: The missing link. The Journal of Immunology 2002, 169(8):4408-4416.
186. Zheng N.Y., Wilson K., Wang X., Boston A., Kolar G., Jackson S.M., et al. Human immunoglobulin selection associated with class switch and possible tolerogenic origins for C delta class-switched B cells. The Journal of Clinical Investigation 2004, 113(8):1188-1201.
187. Zikherman J., Parameswaran R., Weiss A. Endogenous antigen tunes the responsiveness of naive B cells but not T cells. Nature 2012, 489(7414):160-164.